121 related articles for article (PubMed ID: 34382369)
21. The Role of PALB2 in the DNA Damage Response and Cancer Predisposition.
Nepomuceno TC; De Gregoriis G; de Oliveira FMB; Suarez-Kurtz G; Monteiro AN; Carvalho MA
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28858227
[TBL] [Abstract][Full Text] [Related]
22. Familial wild-type gastrointestinal stromal tumour in association with germline truncating variants in both SDHA and PALB2.
Whitworth J; Casey RT; Smith PS; Giger O; Martin JE; Clark G; Cook J; Fernando MS; Taniere P; ; Maher ER
Eur J Hum Genet; 2021 Jul; 29(7):1139-1145. PubMed ID: 33854214
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer family.
Yang C; Arnold AG; Trottier M; Sonoda Y; Abu-Rustum NR; Zivanovic O; Robson ME; Stadler ZK; Walsh MF; Hyman DM; Offit K; Zhang L
Breast Cancer Res Treat; 2016 Dec; 160(3):447-456. PubMed ID: 27757719
[TBL] [Abstract][Full Text] [Related]
24. A systematic review of predicted pathogenic PALB2 variants: an analysis of mutational overlap between epithelial cancers.
Janssen B; Bellis S; Koller T; Tischkowitz M; Liau SS
J Hum Genet; 2020 Jan; 65(2):199-205. PubMed ID: 31619740
[TBL] [Abstract][Full Text] [Related]
25. Frequency and molecular characteristics of PALB2-associated cancers in Russian patients.
Preobrazhenskaya EV; Shleykina AU; Gorustovich OA; Martianov AS; Bizin IV; Anisimova EI; Sokolova TN; Chuinyshena SA; Kuligina ES; Togo AV; Belyaev AM; Ivantsov AO; Sokolenko AP; Imyanitov EN
Int J Cancer; 2021 Jan; 148(1):203-210. PubMed ID: 32997802
[TBL] [Abstract][Full Text] [Related]
26. Compromised repair of radiation-induced DNA double-strand breaks in Fanconi anemia fibroblasts in G2.
Zahnreich S; Weber B; Rösch G; Schindler D; Schmidberger H
DNA Repair (Amst); 2020 Dec; 96():102992. PubMed ID: 33069004
[TBL] [Abstract][Full Text] [Related]
27. Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2.
Schoolmeester JK; Moyer AM; Goodenberger ML; Keeney GL; Carter JM; Bakkum-Gamez JN
Hum Pathol; 2017 Dec; 70():14-26. PubMed ID: 28709830
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and clinical outcomes of germline mutations in BRCA1/2 and PALB2 genes in 2769 unselected breast cancer patients in China.
Deng M; Chen HH; Zhu X; Luo M; Zhang K; Xu CJ; Hu KM; Cheng P; Zhou JJ; Zheng S; Chen YD
Int J Cancer; 2019 Sep; 145(6):1517-1528. PubMed ID: 30720863
[TBL] [Abstract][Full Text] [Related]
29. Germline pathogenic variants in BRCA1, BRCA2, PALB2 and RAD51C in breast cancer women from Argentina.
Cerretini R; Mercado G; Morganstein J; Schiaffi J; Reynoso M; Montoya D; Valdéz R; Narod SA; Akbari MR
Breast Cancer Res Treat; 2019 Dec; 178(3):629-636. PubMed ID: 31446535
[TBL] [Abstract][Full Text] [Related]
30. Coordination of the recruitment of the FANCD2 and PALB2 Fanconi anemia proteins by an ubiquitin signaling network.
Bick G; Zhang F; Meetei AR; Andreassen PR
Chromosoma; 2017 Jun; 126(3):417-430. PubMed ID: 27277787
[TBL] [Abstract][Full Text] [Related]
31. A global functional analysis of missense mutations reveals two major hotspots in the PALB2 tumor suppressor.
Rodrigue A; Margaillan G; Torres Gomes T; Coulombe Y; Montalban G; da Costa E Silva Carvalho S; Milano L; Ducy M; De-Gregoriis G; Dellaire G; Araújo da Silva W; Monteiro AN; Carvalho MA; Simard J; Masson JY
Nucleic Acids Res; 2019 Nov; 47(20):10662-10677. PubMed ID: 31586400
[TBL] [Abstract][Full Text] [Related]
32. Ablation of the Brca1-Palb2 Interaction Phenocopies Fanconi Anemia in Mice.
Park D; Bergin SM; Jones D; Ru P; Koivisto CS; Jeon YJ; Sizemore GM; Kladney RD; Hadjis A; Shakya R; Ludwig T
Cancer Res; 2020 Oct; 80(19):4172-4184. PubMed ID: 32732220
[TBL] [Abstract][Full Text] [Related]
33. Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.
Foo TK; Tischkowitz M; Simhadri S; Boshari T; Zayed N; Burke KA; Berman SH; Blecua P; Riaz N; Huo Y; Ding YC; Neuhausen SL; Weigelt B; Reis-Filho JS; Foulkes WD; Xia B
Oncogene; 2017 Jul; 36(29):4161-4170. PubMed ID: 28319063
[TBL] [Abstract][Full Text] [Related]
34. Alternative transcript imbalance underlying breast cancer susceptibility in a family carrying PALB2 c.3201+5G>T.
Duran-Lozano L; Montalban G; Bonache S; Moles-Fernández A; Tenés A; Castroviejo-Bermejo M; Carrasco E; López-Fernández A; Torres-Esquius S; Gadea N; Stjepanovic N; Balmaña J; Gutiérrez-Enríquez S; Diez O
Breast Cancer Res Treat; 2019 Apr; 174(2):543-550. PubMed ID: 30552643
[TBL] [Abstract][Full Text] [Related]
35. Assessment of PALB2 as a candidate melanoma susceptibility gene.
Aoude LG; Xu M; Zhao ZZ; Kovacs M; Palmer JM; Johansson P; Symmons J; Trent JM; Martin NG; Montgomery GW; Brown KM; Hayward NK
PLoS One; 2014; 9(6):e100683. PubMed ID: 24949998
[TBL] [Abstract][Full Text] [Related]
36. Response to olaparib in a
Horak P; Weischenfeldt J; von Amsberg G; Beyer B; Schütte A; Uhrig S; Gieldon L; Klink B; Feuerbach L; Hübschmann D; Kreutzfeldt S; Heining C; Maier S; Hutter B; Penzel R; Schlesner M; Eils R; Sauter G; Stenzinger A; Brors B; Schröck E; Glimm H; Fröhling S; Schlomm T
Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30833416
[TBL] [Abstract][Full Text] [Related]
37. RNF168-mediated localization of BARD1 recruits the BRCA1-PALB2 complex to DNA damage.
Krais JJ; Wang Y; Patel P; Basu J; Bernhardy AJ; Johnson N
Nat Commun; 2021 Aug; 12(1):5016. PubMed ID: 34408138
[TBL] [Abstract][Full Text] [Related]
38. Mismatch-repair-deficient metastatic pancreatic ductal adenocarcinoma with a germline PALB2 mutation: unusual genetics, unusual clinical course.
Boeck S; Mehraein Y; Ormanns S; Kruger S; Westphalen CB; Haas M; Jung A; Kirchner T; Heinemann V
Ann Oncol; 2017 Feb; 28(2):438-439. PubMed ID: 27803004
[No Abstract] [Full Text] [Related]
39. Targeted massively parallel sequencing characterises the mutation spectrum of PALB2 in breast and ovarian cancer cases from Poland and Ukraine.
Myszka A; Nguyen-Dumont T; Karpinski P; Sasiadek MM; Akopyan H; Hammet F; Tsimiklis H; Park DJ; Pope BJ; Slezak R; Kitsera N; Siekierzynska A; Southey MC
Fam Cancer; 2018 Jul; 17(3):345-349. PubMed ID: 29052111
[TBL] [Abstract][Full Text] [Related]
40. PALB2 c.2257C>T truncating variant is a Greek founder and is associated with high breast cancer risk.
Vagena A; Papamentzelopoulou M; Kalfakakou D; Kollia P; Papadimitriou C; Psyrri A; Apostolou P; Fountzilas G; Konstantopoulou I; Yannoukakos D; Fostira F
J Hum Genet; 2019 Aug; 64(8):767-773. PubMed ID: 31089269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
